Clinical Trial Update: Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a first-line regimen of cyclophosphamide, vincristine, liposomal doxorubicin (Myocet), prednisone, and rituximab for patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Myocet (liposomal doxorubicin)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: Asociacion Doctor Peset Para el Estudio de la Hematología | Conditions: No Hodgkin B Lymphoma | Phase 2 | Status: UNKNOWN